1. Home
  2. ALVR vs WCT Comparison

ALVR vs WCT Comparison

Compare ALVR & WCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVR
  • WCT
  • Stock Information
  • Founded
  • ALVR 2013
  • WCT 2012
  • Country
  • ALVR United States
  • WCT Hong Kong
  • Employees
  • ALVR N/A
  • WCT N/A
  • Industry
  • ALVR Biotechnology: Biological Products (No Diagnostic Substances)
  • WCT
  • Sector
  • ALVR Health Care
  • WCT
  • Exchange
  • ALVR Nasdaq
  • WCT NYSE
  • Market Cap
  • ALVR 46.6M
  • WCT 38.1M
  • IPO Year
  • ALVR 2020
  • WCT 2024
  • Fundamental
  • Price
  • ALVR $9.38
  • WCT $1.82
  • Analyst Decision
  • ALVR
  • WCT
  • Analyst Count
  • ALVR 0
  • WCT 0
  • Target Price
  • ALVR N/A
  • WCT N/A
  • AVG Volume (30 Days)
  • ALVR 29.1K
  • WCT 572.8K
  • Earning Date
  • ALVR 03-14-2025
  • WCT 12-07-2024
  • Dividend Yield
  • ALVR N/A
  • WCT N/A
  • EPS Growth
  • ALVR N/A
  • WCT N/A
  • EPS
  • ALVR N/A
  • WCT 0.05
  • Revenue
  • ALVR N/A
  • WCT $2,370,163.00
  • Revenue This Year
  • ALVR N/A
  • WCT N/A
  • Revenue Next Year
  • ALVR N/A
  • WCT N/A
  • P/E Ratio
  • ALVR N/A
  • WCT $38.78
  • Revenue Growth
  • ALVR N/A
  • WCT N/A
  • 52 Week Low
  • ALVR $7.96
  • WCT $0.94
  • 52 Week High
  • ALVR $24.15
  • WCT $9.36
  • Technical
  • Relative Strength Index (RSI)
  • ALVR 39.33
  • WCT N/A
  • Support Level
  • ALVR $7.96
  • WCT N/A
  • Resistance Level
  • ALVR $10.00
  • WCT N/A
  • Average True Range (ATR)
  • ALVR 1.14
  • WCT 0.00
  • MACD
  • ALVR 0.03
  • WCT 0.00
  • Stochastic Oscillator
  • ALVR 35.50
  • WCT 0.00

About ALVR AlloVir Inc.

AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.

About WCT WELLCHANGE HOLDINGS COMPANY LIMITED

Wellchange Holdings Co Ltd is an enterprise software solution services provider. It provides software solutions, cloud-based software-as-a-service (SaaS) platforms, and white-label software design and development services.

Share on Social Networks: